Prevalence and Consequences of Guideline-Directed Indications for Aortic Valve Replacement in the EARLY TAVR Trial

Madhavan MV, Schwartz A, Lindman BR, Pibarot P, Cohen DJ, Oldemeyer JB, Babaliaros V, Fearon WF, Daniels D, Chhatriwalla A, Kavinsky CJ, Shah P, Szerlip M, Dahle T, Goel K, O'Neill W, Makkar R, Davidson C, Sheth T, Sorajja P, DeVries J, Southard J, Depta JP, Pop A, Hahn RT, Zhao Y, Leon MB, Genereux P; EARLY TAVR Trial Executive Committee and Study Investigators. Prevalence and Consequences of Guideline-Directed Indications for Aortic Valve Replacement in the EARLY TAVR Trial. JACC Cardiovasc Interv. 2026 Nov 9;19(21):2876-2888. doi: 10.1016/j.jcin.2026.08.016. PMID: 43003599.


Related Posts